IRIS
RONCATO, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 766
EU - Europa 396
AS - Asia 217
AF - Africa 17
SA - Sud America 6
Totale 1.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 760
SG - Singapore 134
IT - Italia 107
RU - Federazione Russa 87
CN - Cina 45
IE - Irlanda 44
DE - Germania 31
IN - India 21
CH - Svizzera 15
FI - Finlandia 15
GB - Regno Unito 15
TG - Togo 15
UA - Ucraina 15
FR - Francia 14
NL - Olanda 13
AT - Austria 12
CZ - Repubblica Ceca 11
TR - Turchia 7
BR - Brasile 5
CA - Canada 5
SE - Svezia 5
BE - Belgio 3
ES - Italia 3
HK - Hong Kong 3
LT - Lituania 2
OM - Oman 2
SA - Arabia Saudita 2
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
IR - Iran 1
KZ - Kazakistan 1
MA - Marocco 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
Totale 1.402
Salva come PNG Salva come JPEG
Città #
Singapore 114
Boardman 75
Fairfield 69
Chandler 68
Ashburn 60
Dublin 44
Houston 38
Woodbridge 38
Cambridge 32
Seattle 30
Wilmington 27
Los Angeles 20
Lomé 15
Zurich 15
Ann Arbor 14
Dearborn 13
Ogden 12
Pune 12
Genoa 11
Beijing 10
Brno 10
Dallas 10
Munich 9
Nuremberg 9
Princeton 9
Arezzo 8
Helsinki 8
London 8
Redmond 8
Hyderabad 7
Amsterdam 6
Jacksonville 6
Udine 6
Vienna 6
Milan 5
Cormons 4
Deiva Marina 4
Frankfurt am Main 4
Izmir 4
Lappeenranta 4
New York 4
Santa Clara 4
Xi'an 4
Zoppola 4
Brussels 3
Codroipo 3
Cologne 3
Guangzhou 3
Hong Kong 3
Naples 3
Shenzhen 3
São Paulo 3
Thetford 3
Toronto 3
Azzano Decimo 2
Belluno 2
Des Moines 2
Gorgonzola 2
Innsbruck 2
Leawood 2
Lissone 2
Madrid 2
Mirano 2
Monza 2
Muscat 2
Novara 2
Porcia 2
Riyadh 2
Roccamonfina 2
Romans d'Isonzo 2
Rome 2
San Diego 2
San Giorgio di Nogaro 2
Vaestra Froelunda 2
Venice 2
Vercelli 2
Ahmedabad 1
Almaty 1
Andover 1
Ardabil 1
Barking 1
Bhubaneswar 1
Borore 1
Cairo 1
Caorle 1
Changzhou 1
Conselheiro Lafaiete 1
Coos Bay 1
Cordenons 1
Delft 1
Duque de Caxias 1
Fayetteville 1
Fuzhou 1
Jinan 1
Krakow 1
La Paz 1
Monfalcone 1
Nanchang 1
Nanjing 1
Nanning 1
Totale 966
Salva come PNG Salva come JPEG
Nome #
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) 121
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity 98
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 84
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines 77
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 72
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 51
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer? 43
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 41
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 37
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 37
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 34
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk 34
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 33
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 33
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients 31
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 30
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 28
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches 27
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy 27
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype 26
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm 26
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome 25
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients 24
Implementation of preemptive testing of a pharmacogenomic panel in clinical practice: Where do we stand? 24
Abstract PD10-01: Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach 23
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection? 23
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS) 21
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 20
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 20
European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology 19
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine 19
Pharmacovigilance, drug interactions, pharmacogenetics and therapeutic drug monitoring of anticancer agents: a valuable support for clinical practice 19
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach 18
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 18
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (Cell Death & Disease, (2022), 13, 4, (398), 10.1038/s41419-022-04741-9) 18
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer 18
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 18
Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation? 17
Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice 17
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 17
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions 17
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 17
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 16
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 16
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients 16
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 15
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma 15
Genetic biomarkers for hepatocellular cancer risk in a caucasian population 15
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation 15
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity 14
Improving decision making on DPYD and UGT1A1*28 patients' profiling with an innovative reimbursement strategy 12
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 11
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer 11
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug–gene interactions 11
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment 11
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation 8
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study 7
Totale 1.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 0 21 21 13 3 5
2020/2021127 3 6 19 16 8 11 28 11 8 5 7 5
2021/202266 3 5 0 4 2 2 11 0 4 10 14 11
2022/2023318 9 3 4 77 59 70 0 22 45 4 9 16
2023/2024339 31 19 11 4 39 40 21 15 19 31 25 84
2024/2025515 53 87 42 40 88 71 91 43 0 0 0 0
Totale 1.595